Recruitment And Diversity

81. Advancing Rare Disease Research With Patient Registries 6/16/2023

    In this Q&A, “Rare dad” Harsha Rajasimha, Ph.D. of IndoUSrare discusses the current state of rare disease research and explains how patient registries can help propel drug development for rare disease therapies. 

82. Age Diversity In Clinical Trials: Why It Matters 6/1/2023

    Clinical trials are essential for evaluating the safety and efficacy of new treatments before they are approved for use by patients. However, a new report from the International Longevity Centre (ILC), in collaboration with RBW Consulting, highlights a significant problem in the clinical trial process: the underrepresentation of older adults. 

83. A Day In The Life Of A Wannabe Clinical Trial Participant: Desperately Seeking Recruitment 4/19/2023

    Over 80% of clinical trials experience low or slow enrollment. And to compound the issue, more than 90% of sites have said they do not have adequate staff to perform recruitment activities. No wonder Leanne Woehlke's attempt at becoming a trial participant didn't pan out quite as she expected.

84. AI And Healthcare Disparities: Driving A Wedge Or Closing The Gap? 3/31/2023

    The enthusiasm for the role of AI in upgrading global health and care provision is justified, provided we understand that the path to success is just as much about communication and collaborative development as it is about the raw potential of the technology itself. Because realizing this technological potential requires us to consider the role of people and processes in an integrated approach.

85. Anti-Aging Drugs Need FDA Support And Increased Clinical Trial Participation By Older Adults 2/27/2023

    Though the field of gerotherapeutics is still in its infancy — no drug has yet been approved to prolong health span or lifespan — the need for older adults to participate in clinical trials is expected to increase as these drugs move through the development pipeline.

86. Improving Health Literacy: Breaking Barriers To Quality Cancer Care 2/24/2023

    Cancer care often revolves around what’s new, from the latest methods to detect and diagnose cancer to groundbreaking treatments. But an old challenge persists: Limited health literacy can stand between patients and breakthrough treatments. Pfizer's Dany Habr discusses way to improve patient literacy across multiple channels.

87. How Africa Can Help Reverse Underrepresentation In Clinical Trials 2/13/2023

    In the U.S., 13% of the population is Black, yet only 5% are represented in clinical trials. Historical knowledge tells us a similar disparity exists globally for African representation in clinical trials. Tina Barton, COO of eMQT Ltd., declares now as the time to overcome fears and hesitations to bring more clinical trials to Sub-Saharan Africa.

88. Underrepresentation & Overconsumption: Exploring The Gap In Global Clinical Trial Diversity 2/8/2023

    It is well known that certain ethnic groups are routinely underrepresented in global clinical trials. But another data set now shows that some of those ethnic groups are also disproportionately consuming pharmaceuticals. Vladimir Misik, of VIARES Academy, explores why that is — and how to rectify it.

89. Expanding Eligibility — And 6 More Tips For Improving Trial Diversity 1/20/2023

    It is no secret that people who are ethnically diverse are underrepresented in clinical trials, and that is a trend that needs to change. But how? Discover six ways you can increase trial diversity starting now.

90. How Can Clinical Research Better Navigate Healthcare Deserts? 1/17/2023

    Large swaths of the U.S. remain healthcare deserts, where access to clinical sites, pharmacies, and hospitals is limited. This contributes to underrepresentation in clinical research. What are the roles of technology and community outreach, and what are some current industry efforts to address it?